Literature DB >> 7014787

Immunocytochemical localization of thymosin-alpha 1 in thymic epithelial cells of normal and myasthenia gravis patients and in thymic cultures.

M C Dalakas, W K Engel, J E McClure, A L Goldstein, V Askanas.   

Abstract

Thymosin alpha 1 (alpha 1) is a potent thymic polypeptide hormone. With antibodies against synthetic thymosin alpha 1, indirect immunofluorescence was applied to human normal thymus and to hyperplastic, thymomatous or "involuted" thymus of myasthenia gravis (MG) patients. Alpha 1 was localized only in the epithelial cells, lying singly, grouped, in Hassall's corpuscles or proliferated in thymomas. In contrast to normal thymus, which had fewer and more weakly stained cells, MG hyperplastic thymus had many strongly positive epithelial cells: this was markedly evident in thymomas. "Involuted" MG thymus had a few but brightly stained cells lying within the fatty tissue. In tissue cultures of human thymus, anti-alpha 1 stained the epithelial cells, but not fibroblasts. These findings: (a) demonstrate the origin of the thymic hormone alpha 1 to be the thymic epithelial cell; (b) raise the possibility that excess alpha 1 may act pathologically to facilitate and perpetuate the dysimmune mechanism in MG; (c) may partially explain the beneficial effect of thymectomy in MG patients of any age; and (d) suggest that epithelial cells may be autonomous for the production of alpha 1 as evidenced by their positivity in tissue culture.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014787     DOI: 10.1016/0022-510x(81)90170-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Functional anatomy of the thymic microenvironment.

Authors:  M D Kendall
Journal:  J Anat       Date:  1991-08       Impact factor: 2.610

2.  Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases.

Authors:  M Chilosi; A Iannucci; F Menestrina; M Lestani; A Scarpa; F Bonetti; L Fiore-Donati; B DiPasquale; G Pizzolo; G Palestro
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

3.  Synthesis and apparent secretion of prothymosin alpha by different subpopulations of calf and rat thymocytes.

Authors:  F J Franco; C Diaz; M Barcia; P Arias; J Gomez-Marquez; F Soriano; E Mendez; M Freire
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

4.  Immunohistochemical studies on a human thymic epithelial cell subset defined by the anti-cytokeratin 18 monoclonal antibody.

Authors:  W Savino; M Dardenne
Journal:  Cell Tissue Res       Date:  1988-10       Impact factor: 5.249

5.  Microenvironments in the normal thymus and the thymus in myasthenia gravis.

Authors:  M Bofill; G Janossy; N Willcox; M Chilosi; L K Trejdosiewicz; J Newsom-Davis
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

6.  Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction.

Authors:  G Inghirami; M Chilosi; D M Knowles
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

7.  Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.

Authors:  W Savino; G Manganella; J M Verley; A Wolff; S Berrih; P Levasseur; J P Binet; M Dardenne; J F Bach
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

8.  Thymic hyperplasia. II. Lymphofollicular hyperplasia of the thymus. An immunohistologic study.

Authors:  W J Hofmann; P Möller; H F Otto
Journal:  Klin Wochenschr       Date:  1987-01-15

9.  Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

Authors:  Luigina Romani; Vasilis Oikonomou; Silvia Moretti; Rossana G Iannitti; Maria Cristina D'Adamo; Valeria R Villella; Marilena Pariano; Luigi Sforna; Monica Borghi; Marina M Bellet; Francesca Fallarino; Maria Teresa Pallotta; Giuseppe Servillo; Eleonora Ferrari; Paolo Puccetti; Guido Kroemer; Mauro Pessia; Luigi Maiuri; Allan L Goldstein; Enrico Garaci
Journal:  Nat Med       Date:  2017-04-10       Impact factor: 53.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.